Vertex Joins Forces with the Foundation for Peripheral Neuropathy as 2025 Premier Impact Partner
The Foundation for Peripheral Neuropathy (FPN) is proud to announce an exciting new partnership with Vertex Pharmaceuticals, as an esteemed 2025 Premier Impact Sponsor. This collaboration marks a significant milestone in FPN’s mission to advance patient education for individuals affected by peripheral neuropathy (PN).
Collaboration for Impact
At FPN, our commitment to improving the lives of those living with peripheral neuropathy is unwavering. From advocating for increased awareness to funding groundbreaking research, we strive to make meaningful progress in understanding and treating this complex condition. By joining forces with Vertex, we are bolstering our efforts to provide support and resources to individuals living with this condition and their families and caregivers.
Peripheral neuropathy impacts millions of people worldwide, causing symptoms such as numbness, tingling, and pain in the extremities. It can be debilitating, impacting daily activities, and diminishing quality of life. Vertex shares our dedication to enhancing patient care and improving health outcomes. Through their innovative research, cutting-edge technologies, and commitment to community engagement, they have demonstrated a profound understanding of the challenges faced by individuals with peripheral neuropathy. Together, we will leverage our collective expertise and resources to drive advancements in diagnosis, treatment, and ultimately, finding cures.
As we embark on this journey together, we extend our heartfelt gratitude to Vertex for their unwavering support and commitment to our shared mission.
About the Foundation for Peripheral Neuropathy (FPN)
The Foundation for Peripheral Neuropathy is a non-profit organization dedicated to improving the lives of individuals affected by peripheral neuropathy through awareness, research, advocacy, and education. FPN strives to increase awareness of peripheral neuropathy, provide resources for patients and caregivers, and fund innovative research to advance the understanding and treatment of this condition.
For more information about corporate partnerships like these, please reach out to Lindsay Colbert, Executive Director, at [email protected].
About Vertex
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people living with serious diseases, with a focus on specialty markets. Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London.
